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Abstract
Exposure Therapy: Stimulus Intensity as a Factor in Treatment Preference
Matthew C. Arias
Currently, a host of treatments are available for treating anxiety disorders, including specific
phobia. Treatment of specific phobia includes pharmacological, psychosocial, and combined
approaches. Exposure therapy, however, is considered the leading psychological treatment for
specific phobia, and has shown to be effective. Exposure therapy challenges held beliefs about
feared stimuli/situations and attempts to integrate new learning about the feared object/situation.
Despite exposure being effective to treat specific phobia, it is associated with low adherence and
high dropout rates. There is a need to examine, therefore, ways to improve patient adherence for
exposure. A way to examine this issue is to assess patient preferences for currently available
treatments for specific phobia, and to examine directly the various methods for delivering
exposure (e.g., stimuli intensity presentation). Furthermore, it is important to assess individuals’
perception of efficacy on various methods of delivering exposure stimuli (e.g., low intensity
versus high intensity). Also, it is essential to examine individual willingness to engage in
different presentation of stimuli intensity. Participants (N = 1,065) were assessed for dental carerelated fear and anxiety, and 279 of those individuals with high levels of fear/anxiety were
included in the analyses regarding treatment preferences. Participants rated their preference for
types of treatments (e.g., exposure, flooding, systematic desensitization) and were asked to rank
order-based on personal preference. Then participants watched two video examples of exposure
(i.e., low intensity and high intensity) and asked to rate their preference for the two methods to
deliver exposure stimuli. After, participants rank ordered several approaches for delivering
exposure stimuli by personal preference. Finally, participants were given a free choice to watch
either a black screen (e.g., avoidance), low intensity exposure video, or high intensity exposure
video over three trials. Results indicated that participants rated relaxation as the most preferred
type of treatment for dental phobia. In regard to exposure stimuli, participants rated the low
intensity exposure stimuli with greater preference (e.g., more efficacious and more willing to
engage in the treatment) than the high intensity exposure stimuli. A majority of participants
watched the low intensity (39.6%) and the avoidance video (32.8%) two or more times over the
three trials demonstrating a behavioral preference for video content. A Latent Class Analysis
suggested distinct groups (i.e., Low to Avoidant, and Avoidant) based on the patterns of video
choice over the three trials. Findings of this study highlight differences in patient preferences for
specific phobia treatment, which ultimately can impact oral health care services and training.
Utilizing low intensity exposure stimuli may be a promising way to get patient buy-in and ease
into higher intensity stimuli and possible improve treatment outcomes.
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Exposure Therapy: Stimulus Intensity as a Factor in Treatment Preference
A myriad of treatments are available for treating anxiety disorders, including specific
phobia. Psychotherapy for the treatment of specific phobia ranges from developing alternative,
positive thoughts about the feared stimulus/situation, to uncovering unconscious processes that
contribute to the experience of anxiety, to experiencing situations in which fearful responding is
challenged with new learning. Despite the availability of various treatments for phobia, less than
50% of affected people utilize any available treatment for this disorder (Wang et al., 2005).
Exposure therapy, a specific Cognitive Behavior Therapy (CBT) method, has been shown to be
efficacious and is considered a leading treatment for specific phobia; however, it often has low
utilization rates (Choy, Fyer, & Lipsit, 2007; Daflos & Whittal, 2012; Wolitzky-Taylor,
Horowitz, Powers, & Telch, 2008). Moreover, dropout is common with exposure, and has rates
as high as 45% for specific phobia treatment (Choy et al., 2007). Exposure treatment may be
perceived and experienced as particularly challenging difficult by patients because the goal is to
change fear responding by purposely contacting fear-evoking stimuli and situations.
Given the issues of low utilization and high dropout, there is a need to examine what
patients prefer and will tolerate in the treatment of phobia involving exposure. One salient factor
related to patient preference in exposure treatment is the level of stimulus intensity. For example,
actually flying on an airplane would be a high intensity step for someone with a phobia of flying.
In this case, a contrasting low intensity exposure would be sitting in an airport, without a planned
airline trip. Successfully boarding and flying on a plane would be an end goal for someone with a
phobia of flying, and would be an ideal exposure situation, but few patients would prefer or
tolerate that step early in treatment. There are one-session exposure treatments for specific
phobias (Davis, Ollendick, & Ost, 2012), but they are daunting for many patients.
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Patient preference is believed to relate to patient adherence, defined as “the ability of an
individual to conform to a treatment regimen…as outlined by a health care provider” (American
Psychological Association, 2015, p. 21). Adherence in relation to psychotherapy at least involves
a patient attending psychotherapy sessions, active engagement in those treatment sessions, and
completing out-of-session homework assignments. The importance of this issue is that even the
most effective treatments must be accepted and utilized by patients for positive outcomes to
occur (McNeil, 2011).
Specific Phobia
Specific phobia is one of the anxiety disorders as defined by the Diagnostic and
Statistical Manual of Mental Disorders, 5th edition (DSM-5), and is the experience of fear related
to a particular stimulus/situation, worry related to encountering the feared object/situation, and
hindrance of daily functioning (American Psychiatric Association, 2013). The DSM-5 has five
category types of specific phobia: Animal, Natural Environment, Situational,
Blood/Injection/Injury, and Other. Prevalence rate for specific phobia is 8.7%, and over 20% of
those with a specific phobia are considered in the severe category (Kessler et al., 2005). This
study involved individuals with high levels of dental care-related fear/anxiety as an exemplar for
specific phobia (McNeil & Randall, 2014) due to high prevalence rates (e.g., up to 20%) in the
USA and similar avoidant behaviors as observed in other phobias (Smith & Heaton, 2003).
Psychosocial Treatments for Specific Phobia
Cognitive behavior therapy (CBT). CBT is a common and effective approach for
treating phobia and other disorders, and incorporates behavioral (e.g., extinction) and cognitive
(e.g., thought restructuring) principles. CBT can include many different techniques to help treat
specific phobia, such systematic desensitization, exposure, or flooding (O’Donohue & Fisher,
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2009). Other CBT approaches include thought restructuring (i.e., disputing negative thoughts
about a feared object/situation by examining the evidence) and arousal control (e.g., activating
the parasympathetic nervous system through relaxation, diaphragmatic breathing, and/or
progressive muscle relaxation when encountering feared stimuli).
Exposure therapy. Several forms of exposure therapy exist, such as in vivo (e.g., reallife), in vitro (e.g., role-play), and in imago (e.g., imaginal); see McNeil and Kyle (2017).
Additionally, exposure itself is the basis for systematic desensitization, flooding, and implosive
therapy, although “exposure” has become known as its own method (McNeil & Kyle, 2017).
Systematic desensitization was the first rendition of exposure therapy, developed by Wolpe
(1958), used in combination with relaxation training or medication, and based on classical
conditioning principles. Specifically, systematic desensitization was first based on the theory of
counterconditioning (e.g., maladaptive associations being replaced with adaptive ones by pairing
the fear with something positive; Masters, Burish, Hollon, & Rimm, 1987). Since two
incompatible responses cannot exist simultaneously, systematic desensitization typically utilizes
relaxation training as an incompatible response to anxiety/fear (Masters et al., 1987). Once the
patient is trained in relaxation, then a fear hierarchy is constructed, which is a list and/or
description (typically consisting of 10 – 15 items) of fear/anxiety-evoking situations (Masters et
al., 1987). Typically, the hierarchy increases in intensity, first with early “easy” steps followed
by higher intensity ones over the series, culminating in the goal response (e.g., having a dental
treatment visit for someone with dental phobia; McNeil & Kyle, 2017). The patient works
through the fear hierarchy with the therapist by starting at the first step and practicing relaxation
during imaginal exposure, and then only moves onto the next step when the fear response is no
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longer experienced, or is sufficiently reduced, during the current step (Masters et al., 1987).
Overall, the process is designed to limit the amount of fear experienced by the patient.
A common alternative theory for the effectiveness of systematic desensitization is
extinction, which is a foundational principle in exposure therapy. The intended objective of
exposure therapy is to generate behavior change (e.g., interacting with a feared object/situation),
and to decrease, and ultimately stop, negative reactions to that feared object or situation, also
known as extinction (Pavlov, 1927). When a neutral stimulus (e.g., sight of an anesthetic needle)
is repeatedly paired with an unconditioned stimulus (e.g., pain from the needle prick), it will
cause an unconditioned response (e.g., increased arousal; McNeil & Kyle, 2017). Also, the
neutral stimulus will become a conditioned stimulus and produce a conditioned response (e.g.,
seeing an anestetic needle causes increased arousal; McNeil & Kyle, 2017). With repeated
presentations of the conditioned stimulus in the absence of the unconditioned stimulus,
habituation will occur and the conditioned stimulus will not produce a conditioned response
(e.g., leading to “extinction” or no longer expereincing a fear response; Herry et al., 2010).
Craske et al. (2008) offers a more refined explanation for effectiveness of exposure therapy
based in emotional processing theory, which incorporates the concept of habituation by Groves
and Thompson (1970) and Rachman's (1980) theory of corrective learning. Through emotional
processing, two conditions must be met for a decrease in fear. First, the fear-related stimulus is
presented and activates the fear structure. Second, the new information presented must be
incompatible with information in the fear structure (Foa & Kozak, 1986). Based on the two
purported requirements for successful behavior change, higher intensity stimuli may activate the
fear structure more effectively than low intensity stimuli, which in turn presents greater
opportunity for acquiring incompatible information. Of note, a low intensity stimulus may not be
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sufficiently evocative enough to invalidate previously held beliefs about a fear item/situation,
which would then make the exposure not as effective.
A major goal of exposure therapy is to induce learning about the feared stimulus or
situation that is incompatible with the patient’s negative expectations (Craske, Treanor, Conway,
Zbozinek, & Vervliet, 2014). Inhibitory learning models suggest that the original learned
information about a feared stimulus or situation is not erased from memory, but that exposure
produces additional, new learning about the stimulus/situation (Craske et al., 2014). It is
important for the newly learned information to be incompatible to what is expected when coming
in contact with the stimulus/situation (Craske et al., 2014).
Lang (1971) proposed that a fear structure is the mental representation of a stimulus (e.g.,
needle), response to the stimulus (e.g., increased arousal), and related meaning (e.g., I am in a
dental office and need a root canal to relieve pain). In order to produce corrective learning, the
fear structure must be activated and then new, incompatible information related to the fear
structure must be presented (Foa & Kozak, 1986). In other words, the existing fear structure is
challenged by developing new memories of the stimulus or situation. Exposure therapy allows
for experiences of corrective learning, and can produce habituation (Craske et al., 2008). Lang’s
(1971) conceptualization is consistent with the most current and accepted view of mechanisms
involved in exposure therapy and reason for decreased response (i.e., extinction) is through the
process of habituation and inhibitory learning vis a vis conditioned fear stimuli/situations (Myers
& Davis, 2007).
Expectancy violation and increased arousal are important features in effective exposure
therapy (Craske et al., 2014; Culver, Stoyanova, & Craske, 2012). In order to develop new
learning about the feared object/situation, the exposures should violate the held expectations
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(e.g., frequency or intensity) about the feared object/situation (Craske et al., 2014). In addition to
expectancy violation, increased arousal during the exposure task is associated with longer lasting
treatment gains (Culver et al., 2012). Evidence suggest that increased arousal may optimize
learning during extinction of a fear response (Cain, Blouin, & Barad, 2004). A posited
mechanism is that increased adrenergic activity improves the consolidation of memories (Culver
et al., 2012).
Arousal and expectancy violation are important mechanisms in exposure treatment, but
will only lead to effective treatment and positive outcomes if the patient is willing to engage in
such a treatment. Consequently, it may behoove clinicians to start with low intensity exposure at
the start of treatment to generate willingness to engage in treatment, and then move to higher
intensity exposure that more fully violates patient expectations and generates high arousal for
greater therapeutic change. The approach of starting with low intensity and increasing the level
of intensity with a hierarchy is a common method in delivering exposure. Regardless of the
mechanisms involved, patient adherence and level of stimulus intensity are crucial for
therapeutic gains.
Pharmacological Treatments for Specific Phobia
Medications can be an effective approach to managing anxiety, at least on a temporary
and time-limited basis (Farach et al., 2012). Little evidence, however, exist for medications to be
a stand-alone treatment for specific phobia; nevertheless, medication is often used as an acute
treatment for phobia (Bandelow et al., 2012; Choy et al., 2007). Medications used in anxiety
treatment can include benzodiazepines (i.e., increases GABA levels), selective serotonin
reuptake inhibitors (i.e., increases serotonin level), and/or beta-blockers (i.e., decreases
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norepinephrine levels; Smith, Robinson, & Segal, 2017); various forms of sedation also are
utilized for phobia treatment (Choy et al., 2007).
Benzodiazepines. Wilhelm and Roth (1997) found that a benzodiazepine (i.e.,
alprazolam) decreased anxiety during a flight for patients with flight phobia, but a week later
during another flight without the medication, the patients’ anxiety (e.g., self-report and
physiological reactivity) was higher than a placebo group. Furthermore, a benzodiazepine (i.e.,
midazolam) successfully decreased self-reported anxiety immediately before a dental surgery
compared to a control group, and had the same effect as a one-session psychological treatment
(e.g., relaxation; Jöhren, Jackowski, Gängler, Sartory, & Thom, 2000). Benzodiazepines may be
used on a prn (i.e., when necessary) basis and short-term basis for certain phobias (e.g., flight or
dental phobia; Bandelow et al., 2012).
Selective Serotonin Reuptake Inhibitors (SSRI). The efficacy, tolerance, and safety of
utilizing SSRIs in the treatment of anxiety disorders has shown to be good, and often are
considered the first-line in pharmacological treatment of fear (Bandelow et al., 2012). Several
SSRIs (e.g., escitalopram, paroxetine, fluoxetine, fluvoxamine) have demonstrated effectiveness
in treating a range of specific phobias (e.g., storms, flying, enclosed spaces, heights, dental,
animals; Alamy, Wei Zhang, Varia, Davidson, & Connor, 2008; Balon, 1999; Benjamin, BenZion, Karbofsky, & Dannon, 2000). Despite that SSRIs appear to effectively treat phobia
disorder, a meta-analysis by Roest et al. (2015) suggested that the effectiveness may be
overestimated.
Beta-blockers. Another pharmacological approach is the use of beta-blockers, which
target the physical symptoms often associated with acute anxiety (e.g., shaking hands, sweating,
and increased heart rate) and are prescribed “off-label” (i.e., without FDA approval; Dooley,
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2015). Yaghoobi, Mahmoodiyeh, Khezri, Hashemian, and Fard (2015) found the beta-blocker
propranolol effectively decreased self-reported anxiety prior to a medical surgery. Propranolol
also has been extensively assessed in treating performance anxiety, and has been shown to be
effective (e.g., “stage fright;” Dooley, 2015). Furthermore, Liu, Milgrom, and Fiset (1991) found
that a beta-blocker (i.e., oxprenolol) resulted in lower self-reported anxiety during a needle
injection in a sample of patients with high physiological arousal during a dental visit, and less
pain experienced during the dental visit compared to a control group.
Sedatives. Lastly, general anesthesia and nitrous oxide have also been assessed in
patients with dental phobia as a way to complete dental care-related visits (Choy et al., 2007).
Specifically, Berggren and Linde (1984), comparing general anesthesia and behavioral therapy,
found that in a sample of people who experienced high levels of dental anxiety and avoidance,
general anesthesia was effective in completing two tooth restoration visits and lowering selfreported anxiety. Completion of the dental treatment and likelihood to attend future dental visits,
however, was better for the behavioral therapy group (i.e., 92% completion rate and 78% return
rate) than the anesthesia group (i.e., 69% completion rate and 53% return rate; Berggren &
Linde, 1984). Willumsen, Vassend, and Hoffart (2001) found that nitrous oxide was as beneficial
in lowering dental anxiety as a standard 10-week cognitive/behavioral or cognitive therapy
treatment. Overall, the evidence suggests that medications have the potential to effectively
decrease anxiety experienced in the moment. Armfield and Heaton (2013) posit that individuals
with high levels of anxiety and acute treatment needs may benefit from the use of sedatives as a
form of treatment. However, general anesthesia should be a last resort option for highly anxious
individuals because it only targets the need for dental treatment rather than the anxiety associated
with oral healthcare (Armfield & Heaton, 2013).
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Patient Adherence for Specific Phobia Treatments
Regardless of the form of treatment, effectiveness of virtually all treatments are based on
patient adherence, which is defined as the ability to comply with the treatment as a whole,
including taking medications as prescribed, showing up for and actively participating in
treatment sessions, and doing agreed-upon homework outside of sessions. The available
evidence shows that treatment adherence is variable, and for some individuals, may be poor
(Taylor, Abramowitz, & McKay, 2012). Wheaton et al. (2016) found that for a sample of
patients with obsessive-compulsive disorder (OCD), homework-based exposure tasks were not
conducted by the patients approximately 25% time, which impacted overall treatment.
Furthermore, Simpson et al. (2011) found that adherence to between-session exposure treatment
(i.e., daily exposure tasks that increase in intensity day-to-day) for OCD significantly predicted
decreased symptomology at the end of treatment. In particular, patients with high adherence rates
early in treatment (i.e., lower intensity stimuli) resulted in greater therapeutic gains than those
with high levels of adherence later in treatment (i.e., higher intensity stimuli; Simpson et al.,
2011). Furthermore, patients’ with high adherence to between-session “homework” activities
(e.g., exposure), when receiving CBT for anxiety disorders, reported decreased anxiety compared
to those with low adherence rates (Glenn et al., 2013).
The most significant issue in regard to treatment is patients who drop out prematurely, or
never truly get involved from the beginning, because of negative perceptions or reactions about
the treatment (Taylor et al., 2012). For example, some patients may have thoughts that certain
treatments are too intense (e.g., flooding), that the treatment may not benefit them, or that they
may wish to not use medications. A common problem in CBT is high dropout rates, which have
been shown to range from 9-21% for generalized anxiety treatment and as high as 45% for dental

STIMULUS INTENSITY AS A FACTOR IN TREATMENT PREFERENCE

10

phobia treatment (Choy et al., 2007; Taylor et al., 2012). Some possible reasons for dropout rates
associated with CBT are low motivation for change, patient preference for a different treatment
than what is offered, and/or patient perception that the treatment is not credible (Taylor et al.,
2012). It is important to examine ways to increase adherence with exposure treatment because it
is considered the leading treatment for specific phobia (Wolitzky-Taylor et al., 2008). A possible
factor impacting treatment adherence and decreased dropout is patient preference regarding
specific aspects of treatment (e.g., stimulus intensity for exposure). Swift, Callahan, and Vollmer
(2011) found that clients receiving their preferred treatment were approximately 50% less likely
to drop out of treatment. It is important, therefore, to assess patient preferences for treatment
with the goal to improve overall adherence rates.
Patient Preferences for Type of Treatment
It has been shown that treatment preference is related to treatment outcomes, and patients
may indicate a preference for type of treatment, which may impact overall outcomes (Swift &
Callahan, 2009; Swift et al., 2011). Patient preferences for treatment may lead therapists in
deciding the actual components used in treatment (e.g., with or without exposure). Kazantzis,
Ford, Paganini, Dattilio, and Farchione (2017) found that when a patient states a reluctance to
receive exposure treatment, a clinician is less likely to include exposure as part of treatment (e.g.,
CBT without exposure). A meta-analysis by Adamson et al. (2008) found that when patients’
preference for musculoskeletal pain treatment matches the intervention received, outcomes are
improved. McPherson, Britton, and Wennberg (1997) stated that patient preference and treatment
effect are intertwined, but often not examined in randomized control trials. Treatment preference
is based on knowledge or assumed knowledge on the part of the patient, and how the clinician
describes/presents the treatment. Patients may use a myriad of sources to acquire information
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about treatments, including the internet, which may be accurate or inaccurate depending on the
source of information. Ipser, Dewing, and Stein (2007) state that the quality of information on
anxiety treatment found on the internet, including specific phobia, was moderate to poor, and the
users may be presented with misinformation on how to treat anxiety disorders. Furthermore,
general knowledge about exposure among lay people may be misguided, such that they may
view exposure therapy as unhelpful, unacceptable, and unethical to use for treatment of anxiety
disorders (Richard & Gloster, 2007).
Medication versus psychotherapeutic treatment. Preference for pharmacological over
psychological treatment may differ across disorders, but overwhelmingly for anxiety disorders,
the preferred treatment among patients is psychotherapy (Deacon & Abramowitz, 2005; McHugh
& Whitton, 2013). A meta-analysis indicated that 75% of patients with anxiety disorders prefer
psychological treatments over pharmacological ones (McHugh & Whitton, 2013). In a study
examining treatment preference for older adults diagnosed with an anxiety disorder, 76%
reported a preference for psychological treatment over a pharmacological approach (i.e., 13%) or
a combined approach (i.e., 11%; Mohlman, 2012). It has been shown that pharmacological
treatment and CBT are equally rated by patients diagnosed with an anxiety disorder as
“favorable,” but CBT is rated as more acceptable and effective than pharmacological treatment
(Deacon & Abramowitz, 2005). Of 103 outpatients diagnosed with an anxiety disorder, there
were 74.3% who reported CBT as a first-choice treatment, compared to 25.7% indicating a firstchoice preference for medications (Deacon & Abramowitz, 2005). Additionally, 13% of the
patients indicated a preference to not use medications for anxiety treatment, while 100% of the
patients were favorable about CBT as a treatment method, likely including some who would
prefer its use in conjunction with medications (Deacon & Abramowitz, 2005). Wheaton,
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Carpenter, Kalanthroff, Foa, and Simpson (2016), however, found that 32% of OCD patients
indicated a preference for medication (e.g., risperidone) over exposure treatment. Furthermore,
Jöhren et al. (2000) found that some participants were unwilling to receive psychotherapy and
requested pharmacological treatment with dental phobia; however, the authors did not specify
the percentage of the sample unwilling to receive psychotherapy. Finally, a meta-analysis on
preference for treatment of posttraumatic stress disorder (PTSD) demonstrated a strong
preference for exposure therapy as opposed to a pharmacological approach.
The differences in percentages of patients preferring a certain treatment over another
indicate that therapy should be individually tailored to increase adherence and utilization rates.
Treatment should depend, in part, on the preference of the patient. Some patients, for example,
may indicate a preference for not receiving medications and vice versa. If the treatment
prescribed is different than requested, treatment adherence may be low.
CBT versus other psychotherapeutic treatments. Literature examining patient
preferences for various forms of psychological treatment (e.g., psychodynamic versus CBT) is
sparse. Bragesjö, Clinton, and Sandell (2004), however, found that the general public rates CBT
as more credible, helpful, and preferred compared to psychodynamic psychotherapy. Similarly,
Frövenholt, Bragesjö, Clinton, and Sandell (2007) found that the general public rated an
overwhelming preference for CBT over psychodynamic or cognitive therapy; however, patient
samples were more likely to prefer psychodynamic and cognitive therapy over CBT (Frövenholt
et al., 2007). In a study examining treatment preference for older adults diagnosed with anxiety
problems, 29% reported a preference for CBT, which was greater than supportive therapy (i.e.,
27%), psychodynamic therapy (i.e., 7%), and acceptance-based therapy (i.e., 4%; Mohlman,
2012). Furthermore, Johansson, Nyblom, Carlbring, Cuijpers, and Andersson (2013) found that
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when given a choice between internet-based psychodynamic psychotherapy (IPDT) and internetbased CBT (ICBT) for treatment of major depressive disorder, patients were two times as likely
to choose the ICBT over the IPDT.
Increasing Willingness to Engage in Exposure Treatment
Given that CBT, which includes exposure therapy, is the gold standard and preferred by
some patients and particularly those with an anxiety disorder, it is important to examine ways to
improve willingness to engage in the treatment. Treatment preferences have been seen to impact
overall engagement and utilization of treatment, and it is important to examine preferences
regarding factors that are exposure treatment-specific. For example, level of stimuli intensity is
particularly important in exposure therapy, as higher intensity stimuli typically are associated
with the ultimate goal of exposure treatment. If the intensity of a stimulus is too great, however,
then adherence might be low. On the other hand, if the intensity of the stimulus is too weak, then
little to no therapeutic change may occur. Systematic desensitization paved the way for the
development and fine tuning of exposure therapy. Wolpe (1958) made the assumption that
patients should experience little to no anxiety during the process of exposure to allow
counterconditioning to occur. Current understandings of exposure therapy do not support that
theory, but Wolpe may have uncovered something important in how exposure should be
presented to patients (e.g., starting with low intensity) to increase treatment adherence. For
example, a recent study found good adherence rates (i.e., watching an exposure video more than
one time a day on average) of participants with high levels of dental care-related fear in a twoweek exposure treatment, which could be attributed to the low intensity of the videos watched
(Arias & McNeil, 2019). Moreover, individuals appear to prefer a CBT- and/or exposure-based
treatment for PTSD, but rate exposure-based treatments as highly uncomfortable (Tarrier,
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Liversidge, & Gregg, 2006). Thus, easing into exposure stimuli (i.e., low intensity first) may
decrease thoughts about experiencing discomfort within treatment.
It has been shown that utilizing a “random” approach to presentation of graded exposure
stimuli (e.g., varying levels of difficulty) is as effective in treating phobia with exposure in
comparison to proceeding sequentially from the lowest to the highest (Lang & Craske, 2000;
Rowe & Craske, 1998). Masters et al. (1987) suggest that stimuli presentation should start at the
lowest and gradually increase for highest levels of patient adherence, but going in a descending
order or only completing the highest three exposure steps also demonstrates effective fear
reduction. However, experiencing the higher levels of stimuli intensity, particularly early in
treatment, may lead to increased patient dropout because of the greater distress (Masters et al.,
1987). Thus, it may not be necessary in terms of efficacy to present the exposure stimuli in
ascending order, but that approach may be crucial for some patients to stay in treatment. For
example, if the patient prefers to limit the distress and anxiety experienced, then using a low
intensity stimulus to begin with may improve treatment adherence and decrease dropout.
Although many studies have assessed patient preference and beliefs about exposure therapy
compared to medication or other psychotherapy treatments (Jaeger, Echiverri, Zoellner, Post, &
Feeny, 2009), few studies have directly assessed patient preference for various formats (e.g., low
intensity versus high intensity content) of delivering exposure therapy. Thus, it is important to
assess patient preferences for stimulus intensity and presentational approach in order to increase
overall treatment adherence.
Statement of the Problem
A common issue in the delivery of psychotherapy is adherence at levels that inhibit
therapeutic gains, especially when exposure therapy is the proposed treatment (Simpson et al.,
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2011; Taylor et al., 2012; Wheaton et al., 2016). Nevertheless, previous research has
demonstrated that exposure therapy can effectively be used to treat phobias and other anxiety
disorders (Hellström & Öst, 1995; Michelson, Mavissakalian, Marchione, Dancu, & Greenwald,
1986; Schneider, Mataix-Cols, Marks, & Bachofen, 2005). There are various options for
treatment of specific phobia (e.g., exposure, medications, supportive therapy, muscle relaxation),
and each of these may be affected by the patient’s decision to not pursue treatment and to
continue avoidance. Patients may be hesitant to receive exposure treatment because the goal is to
challenge fears by coming in contact with the feared stimulus/situation. These avoidant
behaviors with many specific phobias are possible because of their circumscribed effects on
quality of life. Little is known about preferences for treatment among individuals in the general
population who have specific phobia. The intensity of the presented exposure stimuli is one
factor that may influence adherence to treatment. It is important to assess how to balance factors
that might increase patient adherence (e.g., using low intensity stimuli) versus features that may
make a treatment effective (e.g., using high intensity stimuli) in order to evoke therapeutic
change. Low-intensity stimuli might increase patient buy-in and also lead to increased adherence
when a part of an escalating hierarchy of exposure stimuli. Patient preference for treatment of
phobia, thus, is an important factor to consider when developing and utilizing evidenced-based
treatments. Generally, it is important to assess patients’ willingness to engage in exposure
treatment.
Hypotheses
Research Question 1: Preference for Treatment
What percent of the sample from the general population in the USA who report high
levels of dental fear/anxiety prefer which types of specific phobia treatments?
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Hypothesis 1. A majority of participants will report higher levels of preference for
systematic desensitization over exposure, flooding, arousal control alone, medications, or
combinations of these various methods.
Research Question 2: Preference for Stimuli Order
What percent of the sample from the general population in the USA who report high
levels of dental fear/anxiety prefer a certain order of stimulus intensity presentation for exposure
therapy?
Hypothesis 2. A majority of participants will prefer a gradual accelerating approach (low
to high intensity) relative to a high-intensity exposure, low-intensity exposure, gradual
decelerating approach (high to low intensity), or a random approach.
Research Question 3: Perceived Effectiveness and Willingness to Engage in Treatment
How do participants who report high levels of dental fear/anxiety rate the effectiveness of
exposure therapy and their willingness to engage in exposure differ for low and a high intensity
stimuli presentation?
Hypothesis 3a. A majority of participants will choose to view low intensity anxietyrelated video stimuli rather than high intensity anxiety-related video stimuli, as a measure of
behavioral preference for low intensity exposure-related material.
Hypothesis 3b. A majority of participants will rate the high intensity exposure as more
effective in treating their phobia than the low intensity exposure.
Hypothesis 3c. A majority of participants will report greater willingness to engage in the
low intensity exposure compared to the high intensity exposure.
Method
Participants
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Power was determined by the planned analysis of hypothesis 1, utilizing a repeated
measure Analysis of Variance (ANOVA) with one group rating preference on four different
treatment options. According to a power analysis program, G*Power 3 (Faul, Erdfelder, Lang, &
Buchner, 2007), to achieve a power of φ = .95 at a small effect size of .10 with four within
measurements, a sample size of 216 was suggested. In order to allow for incomplete responses,
dropout, and excluding participants based on the exclusion criteria, a total of 1,065 participants
were screened in order to recruit 300 participants.
Data from participants were collected via “Amazon Mechanical Turk (M-Turk),” which
is a web-based tool used for data collection across the world (www.mturk.com). M-Turk workers
are compensated for completing “Human Intelligence Tasks” (e.g., completing the proposed
study). MTurk is regarded as an inexpensive and effective method of obtaining data from diverse
samples, which include greater diversity than college student participant pools (Buhrmester,
Kwang, & Gosling, 2011). Behavioral and psychological research often utilizes MTurk as a
means to collect data, and MTurk-based participants have been shown to have comparable
responses to participants who are part of in-person experiments (Casler, Bickel, & Hackett, 2013;
Crano, Brewer, & Lac, 2014; Mason & Suri, 2012).
Inclusion for participation included self-reported fluency in the English language, being
18 years of age or older, indicating residency in the USA, reporting significant dental carerelated fear/anxiety (e.g., 4+ out of 5 on a single item dental fear question), and completing the
screening phase of the study. Exclusion criteria were self-report of current treatment for phobia
or self-report of taking anti-anxiety medications, and if participants had identical ip addresses
(i.e., three or more times – see validity check section below for more information). Participants
were compensated after completing each phase of the study.
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This study adhered to the guidelines presented by the American Psychological
Association for treatment of human research participants. In order to participate, subjects agreed
to an informed consent form that was approved by the West Virginia University Institutional
Review Board, protocol #1801957814.
Video Stimuli
In a prior study on treatment of high dental care-related fear and anxiety, as well as
phobia (McNeil, 2019), 10 publicly-available video clips were identified from YouTubeTM. They
were selected on the basis of being sequential, from low intensity (e.g., entering a dental office)
to high intensity (e.g., highly magnified tooth crown preparation and placement). Subjective
Units of Distress Scale (SUDS; Wolpe, 1973) ratings (i.e., 0-100) were obtained from 29 patients
who participated in systematic desensitization treatment using an Ipad to deliver the stimuli in a
dental operatory. From these 10 videos, two were selected (i.e., video 1 and video 5). Refer to
Appendix A for content of the 10 videos. The videos were selected based on similar length (i.e.,
120 seconds) and self-reported ratings of anxiety experienced when viewing the videos.
In the prior study (McNeil, 2019), participants were allowed to watch each of the 10
videos up to three times and provided SUDS ratings (i.e., highest anxiety experienced during the
video) after watching the video. Mean SUDS ratings across each of the video trials were
calculated to represent anxiety experienced during the 10 videos. Refer to Table 1 for mean
anxiety ratings for the 10 videos. Based on the ratings, video 1 (i.e., low intensity) and video 5
(i.e., high intensity) were selected. A paired samples t-test demonstrated that the high intensity
video (M = 71.1, SD = 19.7) was rated as significantly higher than the low intensity video (M =
43.3, SD = 22.1) in terms of self-reported anxiety, t(28) = 7.86, p < .001.
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There were 30-second trailers created from the two videos and shown to the participants
as an example for the different video intensities (e.g., low and high). The low intensity exposure
video depicted a patient walking into a dental clinic (i.e., video 1 in Appendix A), having a short
conversation with the dental hygienist, and receiving an examination and prophylaxis by a dental
hygienist. The high intensity exposure video included a patient lying supine in a dental chair
receiving injections (i.e., video 5 in Appendix A).
Descriptions of Treatment Options
Definitions from the APA Dictionary of Psychology (American Psychological
Association, 2015) were identified and the different treatment descriptions were presented to
participants who rated preference, expected efficacy, and willingness to engage in the treatment.
Refer to Appendix A.
Self-Report Measures
Demographic and general dental information questionnaire. The questionnaire
consists of 24-items asking about the participants’ age, sex, race/ethnicity, and general dental
information, as well as content related to a larger study. Refer to Appendix C for specific
demographic questions.
Dental Fear Survey (DFS; Kleinknecht, Klepac, & Alexander, 1973). The DFS has 20
self-report items rated on a 5-point Likert-type scale and has a total score ranging from 20 to
100, with higher scores being indicative of increased anxiety and fear related to dental care
(Kleinknecht et al., 1973). Refer to Appendix D. The measure assesses responses (i.e.,
physiological and behavioral) to specific dental situation and circumstances and reflects general
dental care-related anxiety/fear. The DFS consists of three subscales: Dental avoidance and
anxiety, Fear of dental stimuli/procedures, and Arousal associated with dental treatment. The

STIMULUS INTENSITY AS A FACTOR IN TREATMENT PREFERENCE

20

DFS also has a single omnibus item, which was used in the screening phase as a qualification to
participate in the study (i.e., score of 4+ out of 5). The single item has demonstrated high
correlation with the DFS total score (McGlynn, McNeil, Gallagher, & Vrana, 1987). The DFS
has low demand on the participant (e.g., time and cognitive requirements), and is widely used in
behavioral dentistry research. The DFS has demonstrated good reliability (test-retest r = .88) and
validity (α’s ≥ .75; Heaton, Carlson, Smith, Baer, & De Leeuw, 2007; McGlynn et al., 1987).
Preference, treatment effectiveness, and willingness to engage in treatment. In order
to assess preference for types of treatments (i.e., exposure, relaxation, systematic desensitization,
and flooding), a single-item question was used rated on a 5-point Likert-type scale, which is
based on typical approach used for studies included in a meta-analysis examining treatment
preferences (Lindhiem, Bennett, Trentacosta, & McLear, 2014). Refer to Appendix E. Also in
order to assess preference for types of treatments, participants were asked to rank order
treatments from most preferred (i.e., 1) to least preferred (i.e., 6), which included common
approaches for managing phobia (i.e., pharmacological, relaxation, nitrous oxide, systematic
desensitization, exposure, and flooding). Refer to Appendix F.
In order to assess preference for exposure stimuli presentation, participants rated
preference for low intensity stimuli and high intensity stimuli with a single-item question rated
on a 5-point Likert-type scale. Refer to Appendix E. Also, participants were asked to rank order
preference for how stimuli should be presented sequentially to treat their dental fear. Refer to
Appendix G. Similarly in regard to the low intensity and high intensity exposure stimuli,
treatment effectiveness and willingness to engage in treatment were assessed in the same manner
as the first preference question (i.e., 5-point scale). Refer to Appendices H and I.
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Validity checks. In order to ensure accurate responding in the study and that participants
watched the exposure video(s), participants answered five validity checks throughout their
participation in the study (i.e., two in the screening phase and three in the preference phase).
Refer to Appendix J. Participants who answered both validity check questions correctly in the
screening phase were included in the screening analyses. Also, participants who answered two or
more of the three validity check questions correctly in the preference phase were included in the
analyses. Finally, participants with three or more identical ip addresses were dropped from the
analysis to prevent the possibility of duplicate responses from one household. Two identical ip
address were allowed because it was thought reasonable that two people in the same household
may both be MTurk workers.
Behavioral Preference Measure
The two 30-second trailers (i.e., low intensity and high intensity exposure videos) were
presented to the participants in a counterbalanced order. Then participants had the opportunity to
choose to watch the low intensity video, the high intensity video, a black screen (e.g.,
avoidance), or the combination of the three choices a total number of three times. Behavioral
preference for treatment was calculated by number of times each of the options was viewed.
Procedure
Screening Phase
Participants were invited via MTurk to complete the screening phase, which consisted of
the demographic questionnaire, DFS, and two validity questions, as well as two other
instruments not related to the current study. If the participant reported high levels of dental carerelated fear (i.e., 4+ on the single DFS item), then they were invited to participate in the
preference phase of the study. All participants were provided 25¢ after completing the screening
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phase. Those who did not qualify for the preference phase were thanked, and those who did
qualify were invited to participate in the preference phase.
Preference Phase
Participants were provided a series of treatment options with definitions (i.e., systematic
desensitization, exposure, flooding, and relaxation), and then asked to rank order the types of
treatments based on preference. After ranking the various types of treatments, participants
viewed two 30-second trailer videos (i.e., low intensity and high intensity). Order of video
intensity was randomly assigned. After viewing one of the trailers, participants rated level of
preference, perceived efficacy, and their own willingness to engage in that method of exposure
therapy (i.e., low intensity or high intensity). After answering the questions, participants watched
the second trailer (i.e., high intensity or low intensity), and rated level of preference, perceived
efficacy, and their own willingness to engage in the method. Then, participants were offered
their first choice in which video to watch, the 120-second low intensity video, the 120-second
high intensity video, or the120-second black screen video. After watching their first choice of
video, participants were offered again the choice of video to watch next (i.e., 120-second low
intensity video, 120-second high intensity video, or a 120-second black screen). Finally,
participants were again offered the choice of video to watch a third time. After watching the
video(s) three times, participants’ rank ordered their preference for the presentation of exposure
stimuli. Participants were asked to answer a validity check question after watching each video.
Upon completion of the preference phase, participants were awarded an additional $1.00.
Study Analyses
The first hypothesis was assessed by utilizing a repeated measures ANOVA to examine
preferences for different types of treatment for dental fear/anxiety. Furthermore, the rank order
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and percentages of the various types of treatment approaches were examined via Friedman tests,
and planned post-hoc contrasts were examined with Wilcoxon signed-rank tests.
The second hypothesis was assessed by utilizing a repeated measures ANOVA to
examine preferences for various methods for presenting exposure stimuli. Rank order and
percentages for exposure stimuli presentation were also examined via Friedman tests, and
planned post-hoc contrasts were examined with Wilcoxon signed-rank tests. Finally, a Latent
Class Analysis was conducted to assess how different groups of participants emerged based on
which videos were watched over the three trials.
Paired sample t-tests were used to assess the third hypothesis in regard to preference,
perceived effectiveness, and willingness to engage in the two methods for delivering exposure
therapy (i.e., low versus high intensity).
Results
A total of 900 participants were included in the analyses for the screening phase of the
study, and of those participants, 235 were included in the analyses for preference phase of the
study. Refer to figure 1 for a flowchart of participant inclusion/exclusion. Table 2 includes
demographic characteristics and tests for possible group differences between those in the
screening and those in the preference phase.
Hypothesis 1
To assess preferences for various specific phobia treatments, a repeated measure
ANOVA was conducted. Results indicated a significant difference of preference rating (i.e., 0-4
scale) among the four possible treatments, F(2.83, 571.776) = 54.34, p < .001, partial eta2 = .212.
Relaxation (M = 2.0 SD = 1.1) was rated as more preferred than Systematic Desensitization (M =
1.8 SD = 1.2), Exposure (M = 1.6 SD = 1.2), and Flooding (M = .9 SD = 1.2). Systematic
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Desensitization and Exposure did not differ, but both were rated as more preferred than flooding.
Refer to Figure 2.
Also, a Friedman test was used to examine ranked preferences (i.e., 1 most preferred to 6
least preferred) for various types of specific phobia treatment. There was a significant difference
in participant preference rankings, χ2(5) = 283.06, p < 0.001. Planned post-hoc contrasts via
Wilcoxon signed-rank test comparing systematic desensitization and the other options were
conducted with a Bonferroni correction (i.e., p < 0.01). Systematic Desensitization was ranked as
less preferred than Relaxation, more preferred than Exposure or Flooding, and did not differ
from Pharmacological or Nitrous Oxide. Refer to Figure 3.
A post hoc test was conducted to examine participants’ top preferred treatment option
(i.e., relaxation) compared to the other treatments with a Wilcoxon signed-rank test with a
Bonferroni correction (i.e., p < 0.01). Relaxation was ranked as more preferred than Systematic
Desensitization, Exposure, and Flooding.
Hypothesis 2
A Friedman test was utilized to assess ranked preference for various exposure treatment
methods. There was a significant difference in participant preference ratings for various exposure
methods, χ2(4) = 239.35, p < 0.001. Planned post hoc contrasts via a Wilcoxon signed-rank test
comparing a gradual accelerating approach and the other options was conducted with a
Bonferroni correction (i.e., p < 0.0125). The gradual accelerating approach (i.e., Low to High)
was ranked as less preferred than the low-intensity approach, and ranked as more preferred than
the random approach, the gradual decelerating approach (i.e., high to low intensity), and the
high-intensity approach. Refer to Figure 4.
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A post hoc test was conducted to examine participants top preferred exposure method
(i.e., Low intensity) compared to the other methods with a Wilcoxon signed-rank test with a
Bonferroni correction (i.e., p < 0. 0125). The low-intensity approached was ranked as more
preferred than the gradual accelerating approach, random approach, gradual decelerating
approach (i.e., high to low intensity), and high-intensity approach.
Hypothesis 3a
A paired samples t-test was conducted to examine participant ratings of perceived
preference for the low intensity versus the high intensity video content. Participants self-reported
higher preference for the low intensity video content (M = 2.5, SD = 1.2) compared to the high
intensity content video (M = 1.1, SD = 1.3), t(234) = 12.98, p < .001, d = 1.12.
In order to examine level of willingness to engage in various exposure treatments (e.g.,
low intensity versus high intensity), a repeated measures ANOVA was conducted based on total
number of times the different video contents were watched (i.e., 0-3 times). Analysis indicated a
significant main effect for total videos watched, F(1.873, 438.392) = 20.34, p < .001, partial eta2
= .079, such that low intensity (M = 1.3, SD = 1.0) and the black screen (M = 1.1, SD = 1.1) were
watched more than the high intensity (M = .6, SD = .9). Viewing of the black screen and low
intensity videos did not differ.
Total number of times each video type was watched (i.e., 0-3) was used to examine
participant preference for each video type (i.e., low intensity preference, high intensity
preference, avoidance preference, and no preference). A low intensity preference would
correspond to participants who watched the low intensity video two or more times, a high
intensity preferences are those who watched the high intensity video two or more times, an
avoidance preference are individuals who watched the black screen video two or more times, and

STIMULUS INTENSITY AS A FACTOR IN TREATMENT PREFERENCE

26

no preference includes participants who watched each video type only once. A total of 93
(39.6%) participants demonstrated a low intensity preference, 35 (14.9%) showed a high
intensity preference, 77 (32.8%) demonstrated an avoidance preference, and 30 (12.8%)
exhibited no video preference.
A Latent Class Analysis was utilized to assess for differential patterns of watching the
exposure videos. The number of classes extracted were based on various fit indices across
various models with an iterative process (e.g., akaike information criterion, bayesian information
criterion, entropy, and bootstrapped likelihood ratio test; Jung & Wickrama, 2008; Wang &
Wang, 2012). Results suggest a two-class solution with a “Prefer Low Activation” group
(69.5%) and an “Avoidant” group (30.5%). Refer to Table 3 for fit indices and to Figure 5 for
class probabilities with each video choice across the three trials (e.g., the likelihood that a
participant in one of the determined groups would select the low intensity, high intensity, or
black screen at each trial). Thus, class probability ranges from 0% (i.e., no chance of selecting
the video type) to 100% (i.e., participant will definitely choose the video type). The Prefer Low
Activation group had a probability of 60% for choosing the low intensity video for the first trial,
a 57% for the second trial, and 47% chance of choosing it for the third trial. For this group,
participants’ probability of avoiding (i.e., choosing the black screen) increased with each trial,
7%, 15%, and 29%, respectively. Thus, participants in this group were more likely at each
subsequent trial to avoid rather than watch on of the exposure videos. Finally, the Avoidant
group consistently had a greater probability of avoiding the videos over the three trials with 74%
in trial 1, 88% in trial 2, and 86% in trial 3. Furthermore, the probability of selecting the high
intensity video was the least likely in this group.
Hypothesis 3b
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To assess participant ratings of perceived effectiveness for the low intensity versus the
high intensity exposure treatment approach, a paired samples t-test was utilized. Analysis
indicated that participants rated the low intensity exposure (M = 1.8, SD = 1.4) as likely to be
more effective than the high intensity exposure (M = 1.2, SD = 1.3), t(234) = 6.27, p < .001, d =
0.44.
Hypothesis 3c
To assess participant willingness to engage in low intensity treatment versus high
intensity treatment, a paired samples t-test was utilized. Analysis indicated that participants rated
more willingness to engage in the low intensity exposure (M = 2.5, SD = 1.2) than the high
intensity exposure (M = 1.3, SD = 1.4), t(234) = 11.44, p < .001, d = 0.92.
Discussion
A goal of this study was to examine patient preferences for available treatments for
specific phobia, with dental care-related fear, anxiety, and phobia, as an exemplar. Previous
studies have compared patient preferences for pharmacological versus psychological treatment
(McHugh & Whitton, 2013) or CBT versus other psychotherapeutic treatments (Frövenholt et
al., 2007). To date, however, no one has assessed patient treatment preference with an extensive
list of treatments (e.g., medications, exposure, relaxation, nitrous oxide, flooding). Overall,
participants appear to prefer the least intensive approach (e.g., relaxation or a low intensity
exposure). The most illuminating results of the current study may be that participants rated
relaxation as a more preferred treatment than other options, including medications and nitrous
oxide. Although participants rating relaxation as the most preferred option for their dental
fear/anxiety was surprising, evidence supports the approach specifically with dental phobia
(Armfield & Heaton, 2013). Relaxation can help with more than the fear and anxiety experienced
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and may decrease overall pain experienced during a dental visit (Armfield & Heaton, 2013).
Furthermore, the results are consistent with patient preference for CBT treatments compared to
pharmacological treatment for other specific phobias and anxiety disorders more generally
(McHugh & Whitton, 2013). The findings suggest that participants may want help reducing
stress experienced at a dental visit via behavioral training rather than using medications/sedatives
or other psychological approaches (e.g., exposure).
Another goal of the current study was to examine patient preference for specific
components involved in exposure therapy (e.g., order of stimuli presentation). Some key factors
that impact exposure effectiveness are learning new information that violates a previously held
fear-structure and increased arousal during the exposure (Craske et al., 2014; Culver et al., 2012;
Foa & Kozak, 1986). Therefore, it was hypothesized that participants would rate a gradual
accelerating intensity as most preferred; however, participants consistently demonstrated a
preference for the low intensity stimuli, which in retrospect may not be surprising given the
nature of exposure therapy (e.g., confronting a fear) and related high levels of dropout and low
levels of adherence (Choy et al., 2007; Taylor et al., 2012). The self-reported preference for low
intensity versus high intensity exposure stimuli was further supported by actual behaviors.
Participants were more likely to watch the low intensity video or avoid the videos completely
than watch the high intensity video across the three trials. The findings suggest when presented
the opportunity to choose between low intensity, high intensity, or avoid altogether, participants
were more likely to choose the low intensity stimuli or avoid the stimuli.
The Latent Class Analysis supports these findings as well and suggests that there were
two distinct groups. Given the previous results of a preference for low intensity or avoidance, it
is not surprising that the most consistent group (e.g., watched the same exposure stimuli intensity
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over the three trials) was those who avoided the videos completely (i.e., Avoidant group). The
second group (i.e., a Low to Avoidant group) again demonstrates a preference for low intensity
stimuli or avoidance, and these individuals appear to be willing to engage in this type of
treatment, at least at low levels. It has been shown that a low intensity exposure for dental fear,
anxiety, and phobia over a two-week period was effective in decreasing self-reported anxiety
during a behavioral avoidance task (Arias & McNeil, 2019). Results suggest that with each trial,
however, the probability of participants avoiding the videos increased, which is inconsistent with
Simpson et al. (2011). The difference could be due to the participants in the present study
watched the same low intensity content rather than systematically increasing stimuli intensity as
in Simpson et al.'s (2011) study. The variety of low intensity stimuli, therefore, may have
improved treatment adherence rates more than just the low intensity stimuli. Based on Arias and
McNeil (2019), however, watching a low intensity exposure may need to persist across several
weeks rather than one session. Furthermore, participants on average were only watching the low
intensity exposure once per day (Arias & McNeil, 2019), which is consistent with the behavioral
pattern of the present participants (i.e., increasing likelihood of choosing the avoid option as the
participants progressed through the three trials).
Finally, the current study assessed patient perceptions about exposure therapy and the
various methods to present stimuli. Similar to the previous findings, participants self-reported the
low intensity exposure as more preferred than the high intensity exposure. Inconsistent with the
proposed hypothesis, however, participants rated the low intensity exposure as likely to be more
effective than the high intensity exposure. The differences, however, may not be clinically
significant, based on the small effect sizes. Nonetheless, participants’ perception for
effectiveness of the two treatment approaches were rated as moderate, which is consistent with
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previous findings (Becker, Darius, & Schaumberg, 2007). Lastly, participants reported a greater
willingness to watch the low intensity exposure videos as compared to watching the high
intensity videos as a method of exposure treatment. Previous research suggests that patients with
high levels of dental care-related fear/anxiety are quite adherent when the stimuli presented was
considered by the patients as low intensity (Arias & McNeil, 2019). The self-reported
willingness to engage in low intensity exposure was further supported by the results of the Latent
Class Analysis; where, most participants (regardless of class) avoided watching the high
intensity videos.
The results of this study highlight important factors that can be considered to improve
efficacy of specific phobia treatment. In particular, clinicians should consider patient preferences
for treatment because they are inherently tied to therapeutic outcomes and patient adherence. A
significant finding was participant preferences for relaxation as a treatment option, which could
easily be integrated into dental practices. Dental care providers can equip and train their patients
to utilize relaxation approaches within the office, which can decrease patient and provider
burden. Furthermore, dental care providers can offer relaxation as a treatment for those with high
levels of dental fear/anxiety with other commonly provided options (e.g., sedation) and allow the
patient to choose based on their preference. Another important finding of this study is that it may
behoove clinicians to consider patient preference when delivering exposure therapy, such as
offering a low intensity approach rather than the typical gradual accelerating approach. Also,
based on previous findings (i.e., Arias & McNeil, 2019) and the results of this study, it may add
to the theoretical approach of exposure therapy, such that a low intensity approach may be
effective and accepted by individuals with dental phobia. Moreover, this study highlights on
perhaps adopting a low intensity approach at first to increase buy-in and adherence before
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moving to higher intensity exposure. Overall, it is important to consider patient preferences in all
areas of treatment, which can improve treatment outcomes and adherence rates.
This study is not without limitations. Despite the positive aspects of MTurk as a source to
collect participant responses, MTurk samples, compared to national samples, may be less
representative of USA demographics (Berinsky, Huber, & Lenz, 2012). Overall, MTurk samples
appear to have higher educated participants (e.g., college degree), more likely to identify as
female, and are more likely to report living in urban areas when compared to national norms
(Huff & Tingley, 2015). A potential problem with MTurk samples is a higher social desirability
bias effect and possible lower engagement compared to research conducted in-person (Peer,
Vosgerau, & Acquisti, 2014). Despite the potential limitations of MTurk, it was chosen to recruit
participants because of the need for a large, generalizable population.
The preference phase of the study had more women enrolled than men, which is a
limitation. However, the rates of men enrolled in the screening phase was approximately even
with women. The difference in men who qualified for the preference phase may not be all that
surprising. It has been shown that men often report lower anxiety levels, whereas women report
higher ones (Craske, 2003). Due to this fact, it may have been better to lower the inclusion
criteria of reporting a 4+ on the DFS item 20 for men to 3+ to have a similar distribution in the
preference phase. Future studies can examine how men who rate a 3 on the DFS item 20 differ
from those who rate a 4 on the item.
Another potential limitation of this study is that there is no way of knowing if the
participants watched the videos attentively, or at all. Steps were taken, however, to ensure the
participants watched the videos in their entirety and the study’s design even provided an option
to avoid (e.g., black screen). Future research can examine if videos watched in a clinic setting
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versus online make a difference in self-reported preference for exposure methods. Also,
participant ratings of perceived efficacy for the exposure methods (i.e., low intensity and high
intensity) may have been confounded by their self-reported preference, which may explain why
participants rated the low intensity approach has more effective than the high intensity approach.
Thus, future studies can examine in greater detail why individuals prefer one method over the
other. Lastly, the study did not provide exposure treatment to the participants, and so the relation
of preferences to efficacy is unknown. Future research should investigate whether educating
patients about the efficacy and speed of impact affects treatment preferences.
Taking into consideration patient preferences for treatment options and methods provides
a host of advantages. Ultimately, the goal for treatments is to be effective, but it is critical that
they be accepted and utilized by patients (McNeil, 2011). A gold standard treatment is useless if
patients are not willing to utilize it. Furthermore, patient preference for various treatments and
perceived effectiveness of the treatments can impact the level of commitment to the regimen,
which can impact treatment outcomes. This study directly assessed preferences for treatment of
specific phobia, and various delivery methods. Results demonstrated that low intensity exposure
was preferred by those with high levels of dental care-related fear and anxiety, was seen as
effective, and was associated with a willingness to engage in the treatment. Furthermore,
participants rated relaxation as the most preferred type of treatment, which could have a direct
impact on dental care-related services and should influence the current state of oral
healthcare.
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(n = 265)

Participants after removing multiple
responses (i.e., 3 or more identical IP
addresses; n = 646)

Participants after removing multiple
responses (i.e., 3 or more identical IP
addresses; n = 254)

Participants agreeing to
participant in preference phase
(n = 245)

Participants after removing those
currently receiving treatment
(n = 235)

Figure 1. Participant Flow for Inclusion in the Study

Participants declining to
participant in preference phase
(n = 9)
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4

Self-Reported Preference Mean

3.5
3
2.5
2

2.0 (1.1)
a

1.8 (1.2)
b

1.6 (1.2)
b

1.5
0.9 (1.2)
c

1
0.5
0
Relaxation

Systematic Desensitization

Exposure

Flooding

Figure 2. Participant Preference for Various Types of Treatments. Columns that do not share a
common superscript differ at p < .05.
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6

5.1
b

Rank Mean

5

4.0
b

4

3

3.0
a

3.1
a

3.3
a

2.5
b

2

1
Relaxation

Pharmacological Nitrous Oxide

Systematic
Desensitization

Exposure

Flooding

Figure 3. Participant ranked preference for types of treatments. Planned post-hoc contrasts via Wilcoxon
signed-rank test comparing systematic desensitization and the other options were conducted with a
Bonferroni correction (i.e., p < 0.01). Columns that do not share a common superscript with Systematic
Desensitization differ at p < .01. Lower ranks indicate a higher preference for that treatment; for example,
a score of one would indicate a first choice option and a score of 6 would indicate last choice option.
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5

Rank Mean

4

3.5
b

3.6
b

Random Approach

High then Low
Intensity

3.7
b

3
2.4
a

2

1.9
b

1
Low Intensity

Low then High
Intensity

High Intensity

Figure 4. Graph of Participant Ranked Preference for Presentation of Exposure Stimuli. Planned post hoc
contrasts via a Wilcoxon signed-rank test comparing gradual accelerating approach (i.e., Low then High
Intensity) and the other options was conducted with a Bonferroni correction (i.e., p < 0.0125). Columns
that do not share a common superscript with Low then High Intensity differ at p < .0125. Lower ranks
indicate a higher preference for that treatment; for example, a score of one would indicate a first choice
option and a score of 6 would indicate last choice option.
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1
Low to Avoidant (n = 205, 69.5%)

0.9

Avoidant (n = 90, 30.5%)
Probability of Selecting the Option

0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
Avoid1

Low1

High1

Trial 1

Avoid2

Low2

Trial 2

High2

Avoid3

Low3

High3

Trial 3

Figure 5. Latent Class Analysis for Videos Watched over the Three Trials. The y-axis is the probability (e.g., likelihood) of selecting the different
video types (i.e., black screen, how intensity, or high intensity) based on which group participants were identified. Avoid1, Avoid2, and Avoid3 is
the black screen option for the three trials. The Low1, Low2, and Low3 is the low intensity option for the three trials. The High1, High2, and
High3 is the high intensity option for the three trials.

STIMULUS INTENSITY AS A FACTOR IN TREATMENT PREFERENCE

50

Table 1
Anxiety Ratings for Exposure Videos Considered for Inclusion in Present Study

Mean (SD)

Video
Length (Sec)

Number of
Participants Who
Watched the Video
in the Prior Study

Video Content

*Video 1

43.3 (22.1)

120

29

Patient walking into a dental clinic. Then the patient had a short
conversation with the dental hygienist. Finally, the dental hygienist
performed an examination and prophylaxis.

Video 2

37.8 (23.0)

29

29

Patient is lying supine in a dental chair being
examined by a dentist.

Video 3

47.7 (24.6)

28

29

Patient receiving a teeth cleaning.

Video 4

54.2 (18.6)

120

29

Dentist performing a scaling on a patient’s teeth.

*Video 5

71.1 (19.7)

120

29

Patient lying supine in a dental chair receiving injections.

Video 6

36.8 (19.7)

44

28

View of an open mouth while a root planning is being performed.

Video 7

61.2 (19.8)

120

28

Dentist drilling into a tooth of a patient.

Video 8

63.2 (19.4)

120

24

A close-up view of a tooth being drilled.

Video 9

61.4 (19.0)

120

14

Patient having a tooth removed.

Video 10

38.5 (16.4)

120

8

Patient receiving a crown on a tooth.

Note. *Videos selected for the current study. Not all participants viewed all 10 videos. SD = standard deviation.
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Table 2
Sample Demographic Characteristics and Tests for Possible Differences
Participants Mean (SD)
Screen

Preference

Statistic

p-value

Combined

Age

38.4 (12.5)

39.5 (12)

t(877) = -1.2

p = .241

38.7 (12.3)

Education

15.5 (2.3)

15.2 (2.1)

t(877) = 1.9

p = .053

15.5 (2.2)

N (%)

N (%)
c2 = 27.2

Sex

p < .001

Female

309 (47.8%)

159 (67.7%)

468 (53.1%)

Male

337 (52.2%)

76 (32.3%)

413 (46.9%)

Statistic

c2 = 1.2

c2 = 29.3

c2 = 3.4

p-value

p = .27

p < .001

p = .064

N (%)

N (%)

Race/Ethnicity*
White
Black/African
American
Latinx/Hispanic

513 (79.4%)

184 (78.3%)

c2 = 1.2

p = .72

697 (79.1%)

63 (9.7%)

47 (16.8%)

c2 = 1.5

p = .22

87 (9.9%)

36 (5.5%)

14 (5%)

c2 = 0.6

p = .44

46 (5.2%)

Asian

51 (7.8%)

22 (7.9%)

c = .1

p = .75

68 (7.7%)

Native American

12 (1.8%)

1 (0.4%)

c2 = 4.4

p = .035

12 (1.4%)

2

Mean (SD)
DFS Total
DFS Item 20

Mean (SD)

40.2 (15.8)

75.8 (15.6)

t(447.52) = -31.4

p < .001

49.7 (22.1)

2.0 (0.8)

4.4 (0.5)

t(670.53) = -52.7

p < .001

2.7 (1.3)

Note. *Percentages equal more than 100% due to participants choosing more than one
race/ethnicity. SD = standard deviation. N = number. Chi-Square analyses were conducted for
sex differences among and between both the screening and preference phase participants. ChiSquare analyses were conducted for race/ethnicity differences between the screening and
preference phase participants.
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Table 3
Fit Indices for Latent Class Analysis
AIC

BIC

ABIC

Entropy

LMR LR

ALMR LR

BLRT

1 class

1855.715

1877.837

1858.809

-

-

-

-

2 class

1729.239

1777.169

1735.943

0.765

p < .001

p < .001

p < .001

3 class

1677.322

1751.062

1687.636

0.838

p = .62

p = .63

p < .001

Note. AIC = Akaike information criterion. BIC = Bayesian information criterion. ABIC = adjusted Bayesian information criterion. LMR LR = LoMendell-Rubin likelihood ratio test. ALMR LR = adjusted Lo-Mendell-Rubin likelihood ratio test. BLRT = bootstrapped likelihood ratio test.
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Appendix A
Exposure Videos Considered for Inclusion in Present Study
1. Patient walking into a dental clinic. Then the patient had a short conversation with the
dental hygienist. Finally, the dental hygienist performed an examination and prophylaxis.
2. Patient is lying supine in a dental chair being examined by a dentist.
3. Patient receiving a teeth cleaning.
4. Dentist performing a scaling on a patient’s teeth.
5. Patient lying supine in a dental chair receiving injections.
6. View of an open mouth while a root planning is being performed.
7. Dentist drilling into a tooth of a patient.
8. A close-up view of a tooth being drilled.
9. Patient having a tooth removed.
10. Patient receiving a crown on a tooth.
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Appendix B
Descriptions of Treatment Options from the APA Dictionary of Psychology
(American Psychological Association, 2015)
“Systematic Desensitization: a form of behavior therapy in which counterconditioning is used
to reduce anxiety associated with a particular stimulus. It involves the following stages: (a) The
client is trained in deep-muscle relaxation; (b) various anxiety-provoking situations related to a
particular problem, such as fear of death or a specific phobia, are listed in order from weakest to
strongest; and (c) each of these situations is presented in imagination or in reality, beginning with
the weakest, while the client practices muscle relaxation. Since the muscle relaxation is
incompatible with the anxiety, the client gradually responds less to the anxiety-provoking
situations.”
“Relaxation: a technique in which the individual is trained to relax the entire body by becoming
aware of tensions in various muscle groups and then relaxing one muscle group at a time. In
some cases, the individual consciously tenses specific muscles or muscle groups and then
releases tension to achieve relaxation throughout the body. Relaxation technique [is] any
therapeutic technique to induce relaxation and reduce stress. Also called relaxation training.
Relaxation therapy [is the] use of muscle-relaxation techniques to aid in the treatment of
emotional tension. Also called therapeutic relaxation.”
“Exposure therapy: a form of behavior therapy that is effective in treating anxiety disorders. It
involves systematic and repeated confrontation with a feared stimulus, either in vivo (live) or in
the imagination. It works by (a) implosive therapy, habituation, in which repeated exposure
reduces anxiety over time by a process of extinction; (b) disconfirming fearful predictions; and
(c) increasing feelings of self-efficacy and mastery. In vivo exposure [is] a type of exposure
therapy, generally used for treating individuals with phobias, obsessive compulsive disorder, and
other anxiety disorders, in which the client directly experiences anxiety-provoking situations or
stimuli in real-world conditions. For example, a client who fears flying could be accompanied by
a therapist to the airport to simulate boarding a plane while practicing anxiety-decreasing
techniques, such as deep breathing. Imaginal exposure [is] a type of exposure therapy used for
treating individuals with anxiety disorders (e.g., phobias, obsessive-compulsive disorder,
posttraumatic stress disorder). Vivid imagery evoked through speech is used by the therapist to
expose the client mentally to an anxiety evoking stimulus.”
“Flooding: a technique in behavior therapy in which the individual is exposed directly to a
maximum-intensity anxiety-producing situation or stimulus, either described or real, without any
attempt made to lessen or avoid anxiety or fear during the exposure. An individual with
claustrophobia, for example, might be asked to spend extended periods of time in a small room.
Flooding techniques aim to diminish or extinguish the undesired response to a feared situation or
stimulus and are used primarily in the treatment of individuals with phobias and similar
disorders.”
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Appendix C
Demographic and General Dental Information Questionnaire
1. What is your sex?
a. Male
b. Female
2. What is your age?
a. ________ years
3. What is your race/ethnicity? Select all that Apply:
a. White/Caucasian
b. Black/African American
c. Hispanic
d. Asian
e. Indian or Alaskan Native
f. Other: ______________
4. What is your marital status?
a. Single
b. Separated
c. Married
d. Divorced
e. Live-in partner
f. Widowed
5. Number of years of education? (For example, High School Diploma = 12 years, College
Degree = 16 years)
a. ______________ years
6. What is your job or occupation?
a. _________________________________
7. What is your current job or occupation status?
a. Working full time
b. Working part time
c. Looking for work – unemployed
d. Retired
e. Disabled – unable to work
8. How do you get to dental appointments?
a. Have a car/truck/vehicle that I primarily or solely use
b. Have a car/truck/vehicle that I share with a spouse/partner
c. Borrow a car/truck/vehicle
d. Have a family member bring me
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e. Have a friend bring me
f. Have a social services agency bring me
g. Other: ____________________________
9. For the vehicle that gets you to dental appointments, how reliably does it run?
Very Unreliable
Very Reliable
0
1
2
3
4
10. What factors make it difficult for you to schedule or attend dental care appointments?
(circle or list all that apply)
a. Hard to get away from work
b. Transportation hard to arrange
c. Not covered by insurance
d. Other: ________________________
11. How long since you last saw a dentist?
a. Within the last 6 months
b. 6 months – 1 year
c. 1 – 2 years
d. 2 – 5 years
e. 5 – 10 years
f. More than 10 years
g. Never saw a dentist
12. When you go to the dentist, what typically gets you to go?
a. Regular cleaning and exam
b. Pain
c. Seeing a cavity or another problem in my mouth
d. Other: _____________________________
13. Do you presently have any dental pain?
No Pain
0
1
2

3

Severe Pain
4

14. Have you had any prior psychological treatment?
a. Yes
b. No
15. If you received previous psychological treatment, what were you treated for? (if this does
not apply to you please respond with N/A)
a. _________________________________________________
b. When did you start treatment? ________________________
c. When did you end treatment? ________________________
d. Are you currently in treatment? _______________________
16. Do you have any extreme fears or phobia? If so, please list.
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a. Yes _____________________________________________
b. No
17. Are you currently taking any medications for mental health issues? If so, please list.
a. Yes _____________________________________
b. No
18. Have you ever taken any medications for mental health issues? If so, please list.
a. Yes _____________________________________
b. No
19. Have you ever received treatment for dental fear? If so, please list treatment(s).
a. Yes ______________________________________
b. No
20. When did you start treatment for your dental fear?
a. __________________________________________
b. Does not apply
21. When did you end treatment for your dental fear?
a. __________________________________________
b. Does not apply
22. Are you currently in treatment for your dental fear?
a. Yes
b. No
c. Does not apply
23. How often do you take medications for fear/anxiety when attending a dental visit?
a. Every time
b. Almost every time
c. More than half of the time
d. Less than half of the time
e. Rarely
f. Never
g. I have never gone to the dentist
24. How often do you use nitrous oxide for fear/anxiety when attending a dental visit?
a. Every time
b. Almost every time
c. More than half of the time
d. Less than half of the time
e. Rarely
f. Never
g. I have never gone to the dentist
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Appendix D
Dental Fear Survey
INSTRUCTIONS: The items in this questionnaire refer to various situations, feelings, and
reactions related to dental work. Please rate your feeling or reaction on these items by using the
following scales. Fill in the appropriate circle which most closely corresponds to your reaction.
Never
1. Has fear of dental work ever caused you
to put off making an appointment?
2. Has fear of dental work ever caused you
__to cancel or not appear for an
__appointment?

A few
times
3

Often

1

Once or
twice
2

4

Nearly
every time
5

1

2

3

4

5

When having dental work done:
3. My muscles become tense…
4. My breathing rate increases…
5. I perspire…
6. I feel nauseated and sick to my
stomach…
7. My heart beats faster…

Not At All A little Somewhat Much Very much
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1

2

3

4

5

Following is a list of things, and situations that many people mention as being somewhat anxiety
or fear producing. Please rate how much fear, anxiety, or unpleasantness each of them causes
you. (If it helps, try to imagine yourself in each of these situations and describe what your
common reaction is.)
Not At
A
Somewhat Much
Very
All
little
much
8. Making an appointment for dentistry.
1
2
3
4
5
9. Approaching the dentist’s office.
1
2
3
4
5
10. Sitting in the waiting room.
1
2
3
4
5
11. Being seated in the dental chair.
1
2
3
4
5
12. The smell of the dentist’s office.
1
2
3
4
5
13. Seeing the dentist walk in.
1
2
3
4
5
14. Seeing the anesthetic needle.
1
2
3
4
5
15. Feeling the needle injected.
1
2
3
4
5
16. Seeing the drill.
1
2
3
4
5
17. Hearing the drill.
1
2
3
4
5
18. Feeling the vibrations of the drill.
1
2
3
4
5
19. Having your teeth cleaned.
1
2
3
4
5
20. All things considered, how fearful are you
1
2
3
4
5
___of having dental work done?
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Appendix E
Treatment Preference
What is your level of preference for the proposed treatment that you just read
about/watched?
Low Preference
0

1

2

3

High Preference
4
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Appendix F
Treatment Preference Ranking
Please rank the following ways to manage your dental fear/anxiety by your preference:
a. Medication
b. Systematic desensitization
c. Relaxation
d. Exposure therapy
e. Flooding
f. Nitrous Oxide
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Appendix G
Stimuli Order Presentation Preference Ranking
Please rank the following ways you prefer to use the videos that you watch in order to
treat your dental fear/anxiety:
a. Low intensity exposure
b. High intensity exposure
c. Low intensity then high intensity
d. High intensity then low intensity
e. Random order of low and high intensity
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Appendix H
Treatment Effectiveness
1. How effective would you consider the LOW intensity exposure videos would be in
treating your dental fear/anxiety?
Ineffective
0

1

2

3

Effective
4

2. How effective would you consider the HIGH intensity exposure videos would be in
treating your dental fear/anxiety?
Ineffective
0

1

2

3

Effective
4
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Appendix I
Willingness to Engage in Treatment
1. How willing would you be to engage in LOW intensity exposure to treat your dental
fear/anxiety?
Unwilling
0

1

2

3

Willing
4

2. How effective would you consider the HIGH intensity exposure videos would be in
treating your dental fear/anxiety?
Unwilling
0

1

2

3

Willing
4

63

STIMULUS INTENSITY AS A FACTOR IN TREATMENT PREFERENCE
Appendix J
Validity Check Question
1. What color are healthy teeth?
a.
b.
c.
d.

Red
Green
White
Black

2. Please select the number four for this question
a.
b.
c.
d.
e.

1
2
3
4
5

3a*. What color outfit was the dental hygienist wearing?
a. Red
b. Black
c. White
d. Yellow
e. Green
3b^. Was the patient wearing glasses in the video?
a. Yes
b. No
4a*. How many people were present most of the time in the video?
a. 1
b. 2
c. 3
d. 4
4b^. The patient in the video...
a. Was clean shaven
b. Had a mustache
c. Had a goatee
d. Had a full beard
5a*. The patient was a
a. Male
b. Female
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5b^. What procedure took place in the video?
a. Tooth extraction
b. Shots to numb the mouth
c. Drilling tooth to fill a cavity
d. Teeth polishing
Note. *represents questions presented after viewing the low intensity video. ^represents
questions presented after viewing the high intensity video.
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